Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Health

Report Published: "PharmEste - Product Pipeline Review - 2013"


Print article Print article
2014-01-27 08:50:28 - Recently published research from Global Markets Direct, "PharmEste - Product Pipeline Review - 2013", is now available at Fast Market Research

Global Market Direct's pharmaceuticals report, "PharmEste - Product Pipeline Review - 2013" provides data on the PharmEste's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, PharmEste's corporate website, SEC filings, investor presentations and featured press releases, both from PharmEste and industry-specific third party sources, put together by Global Markets Direct's team.

Full Report Details at
- www.fastmr.com/prod/769419_pharmeste_product_pipeline_review_201 ..

Scope

* PharmEste - Brief PharmEste overview including business description, key information and facts, and its locations and subsidiaries.
* Review of current pipeline of PharmEste

human therapeutic division.
* Overview of pipeline therapeutics across various therapy areas.
* Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
* Product profiles for late stage and clinical stage products of PharmEste with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
* Recent updates of the PharmEste's pipeline in the last quarter.
* Key discontinued and dormant projects.
* Latest news and deals relating to the products.

Reasons to Get this Report

* Evaluate PharmEste's strategic position with total access to detailed information on its product pipeline.
* Assess the growth potential of PharmEste in its therapy areas of focus.
* Identify new drug targets and therapeutic classes in the PharmEste's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
* Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
* Exploit collaboration and partnership opportunities with PharmEste.
* Avoid Intellectual Property Rights related issues.
* Explore the dormant and discontinued projects of PharmEste and identify potential opportunities in those areas.

Report Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
PharmEste Snapshot
PharmEste Overview
Key Information
Key Facts
PharmEste - Research and Development Overview
Key Therapeutic Areas
PharmEste - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
PharmEste Clinical Stage Pipeline Products
Phase I Products/Combination Treatment Modalities
PharmEste - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
PharmEste - Drug Profiles
PHE-377
Product Description
Mechanism of Action
R&D Progress
PHE-575
Product Description
Mechanism of Action
R&D Progress
TRPA-1 antagonists
Product Description
Mechanism of Action
R&D Progress
PharmEste - Pipeline Analysis
PharmEste - Pipeline Products by Therapeutic Class
PharmEste - Pipeline Products by Target
PharmEste - Pipeline Products by Route of Administration
PharmEste - Pipeline Products by Molecule Type
PharmEste - Pipeline Products by Mechanism of Action
PharmEste - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
PharmEste, Key Information
PharmEste, Key Facts
PharmEste - Pipeline by Indication, 2013
PharmEste - Pipeline by Stage of Development, 2013
PharmEste - Monotherapy Products in Pipeline, 2013
PharmEste - Phase I, 2013
PharmEste - Preclinical, 2013
PharmEste - Discovery, 2013
PharmEste - Pipeline by Therapeutic Class, 2013
PharmEste - Pipeline by Target, 2013
PharmEste - Pipeline by Route of Administration, 2013
PharmEste - Pipeline by Molecule Type, 2013
PharmEste - Pipeline Products by Mechanism of Action, 2013
PharmEste, Other Locations

List of Figures
PharmEste - Pipeline by Top 10 Indication, 2013
PharmEste - Pipeline by Stage of Development, 2013
PharmEste - Monotherapy Products in Pipeline, 2013
PharmEste - Pipeline by Top 10 Therapeutic Class, 2013
PharmEste - Pipeline by Top 10 Target, 2013
PharmEste - Pipeline by Top 10 Molecule Type, 2013
PharmEste - Pipeline Products by Top 10 Mechanism of Action, 2013

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.


Author:
Bill Thompson
e-mail
Web: www.fastmr.com
Phone: 18008448156

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com